Eczema, a problem that behaves like a ‘tenant for life’ once it makes abode in a skin patch, has been a deep mystery for doctors since time immemorial. Numerous case studies have been discussed at length to explain why a particular eczema treatment works wonderfully on some persons, while it turns out to be a dud in others. Why so much disparity in usefulness of eczema treatments among people of dissimilar habits, body types, genetic structures and habitats. The answer is simple yet intricate: the ambiguous factors that have been substantiated as the major catalyst for eczema are autoimmune disorders, a slackened immune system, a body over-clogged with toxins, hyper-sensitive skin in particular areas of the body and so on.
If we try to find one common factor that causes eczema, we’ll come across none. However, things are about to change forever; the scientists appear to have located the ‘evasive cause’ of eczema: the malfunction of a protein called CTIP2 has been blamed as the major culprit for chronic dermatitis. This protein stabilizes the behavior of the body fat, essential for skin health. The latest discovery likely to pay way for an eczema treatment that works equally effectively on people with dissimilar genetic structures, habitats and habits.
A depleted quantity of Ctip2 brings down the lipid level in the skin. Lipids help the skin to sustain its moisture content, flexibility and also prevent allergens from finding a way into exposed epithelium. In the absence of adequate lipid levels, several loopholes develop in the epithelium, paving way for ideal atmosphere for growth of dry, scaly, itchy patches on the skin.
So, are we about to witness a new dawn in the eczema treatment that will wipe out the prolonged existence of a confidence-denting skin condition? Let’s wait and watch!